These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11272609

  • 1. Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease.
    Claviez A, Tiemann M, Wagner HJ, Dreger P, Suttorp M.
    Pediatr Transplant; 2000 May; 4(2):151-5. PubMed ID: 11272609
    [Abstract] [Full Text] [Related]

  • 2. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
    [Abstract] [Full Text] [Related]

  • 3. EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation.
    Kasow KA, Leung W, Horwitz EM, Woodard P, Handgretinger R, Hale GA.
    Pediatr Blood Cancer; 2007 Nov; 49(6):869-72. PubMed ID: 16421900
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
    Dutta R, Miao SY, Phan P, Fernandez-Pol S, Shiraz P, Ho D, Mannis GN, Zhang TY.
    J Med Case Rep; 2021 Mar 28; 15(1):170. PubMed ID: 33773605
    [Abstract] [Full Text] [Related]

  • 5. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
    Barker JN, Martin PL, Coad JE, DeFor T, Trigg ME, Kurtzberg J, Weisdorf DJ, Wagner J.
    Biol Blood Marrow Transplant; 2001 Mar 28; 7(7):395-9. PubMed ID: 11529490
    [Abstract] [Full Text] [Related]

  • 6. [Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation].
    Aimoto M, Yamane T, Inoue A, Momose D, Moriguchi-Aimoto R, Wada-Inoue E, Okamoto S, Koh H, Nakane T, Takeoka Y, Akahori-Nakamae M, Nishiki-Kosaka S, Terada Y, Nakamae H, Koh KR, Nakao T, Ohsawa M, Hino M.
    Rinsho Ketsueki; 2010 Dec 28; 51(12):1775-80. PubMed ID: 21258188
    [Abstract] [Full Text] [Related]

  • 7. Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
    Aisa Y, Mori T, Nakazato T, Suzuki S, Suzuki N, Ikeda Y, Okamoto S.
    Transpl Infect Dis; 2009 Oct 28; 11(5):438-41. PubMed ID: 19497045
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A, Kohno A, Fukuyama R, Elsayed AA, Nakamura S.
    Hum Pathol; 2017 Jan 28; 59():147-151. PubMed ID: 27569297
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host disease.
    Prem S, Al-Shaibani Z, Michelis FV, Kim D, Viswabandya A, Lipton JH, Kumar R, Mattsson J, Law A, Lam W.
    Eur J Haematol; 2019 Nov 28; 103(5):519-522. PubMed ID: 31389104
    [Abstract] [Full Text] [Related]

  • 10. Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation.
    Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R.
    Biol Blood Marrow Transplant; 2019 Jul 28; 25(7):1441-1449. PubMed ID: 30794929
    [Abstract] [Full Text] [Related]

  • 11. Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
    Styczynski J, Tridello G, Gil L, Ljungman P, Hoek J, Iacobelli S, Ward KN, Cordonnier C, Einsele H, Socie G, Milpied N, Veelken H, Chevallier P, Yakoub-Agha I, Maertens J, Blaise D, Cornelissen J, Michallet M, Daguindau E, Petersen E, Passweg J, Greinix H, Duarte RF, Kröger N, Dreger P, Mohty M, Nagler A, Cesaro S.
    J Clin Oncol; 2016 Jul 01; 34(19):2212-20. PubMed ID: 27091716
    [Abstract] [Full Text] [Related]

  • 12. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K, Itoh M, Shimada H.
    Rinsho Ketsueki; 2001 Nov 01; 42(11):1105-10. PubMed ID: 11808079
    [Abstract] [Full Text] [Related]

  • 13. Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia.
    Kawashiri A, Nakagawa SI, Ishiguro C, Mochizuki K, Maeda Y, Kurokawa T.
    J Clin Exp Hematop; 2022 Nov 01; 62(3):175-180. PubMed ID: 36171097
    [Abstract] [Full Text] [Related]

  • 14. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Ali S, AlThubaiti S, Renzi S, Krueger J, Chiang KY, Naqvi A, Schechter T, Punnett A, Ali M.
    Pediatr Transplant; 2019 Feb 01; 23(1):e13319. PubMed ID: 30417487
    [Abstract] [Full Text] [Related]

  • 15. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.
    Transpl Infect Dis; 2009 Oct 01; 11(5):393-9. PubMed ID: 19497070
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr Virus-positive T-cell Lymphoproliferative Disease Following Umbilical Cord Blood Transplantation for Acute Myeloid Leukemia.
    Yui S, Yamaguchi H, Imadome K, Arai A, Takahashi M, Ohashi R, Tamai H, Moriya K, Nakayama K, Shimizu A, Inokuchi K.
    J Nippon Med Sch; 2016 Oct 01; 83(1):35-42. PubMed ID: 26960588
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation.
    Liu L, Zhang X, Feng S.
    Biol Blood Marrow Transplant; 2018 Jul 01; 24(7):1341-1349. PubMed ID: 29530767
    [Abstract] [Full Text] [Related]

  • 18. Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation.
    Kikushige Y, Takase K, Miyamoto T, Numata A, Kamesaki K, Fukuda T, Nagafuji K, Gondo H, Harada M.
    Int J Hematol; 2006 Dec 01; 84(5):441-4. PubMed ID: 17189227
    [Abstract] [Full Text] [Related]

  • 19. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N, Adachi A, Mori T, Kamata H, Nakahara J, Yokoyama K, Yamada T, Kizaki M, Sakamoto M, Ikeda Y, Okamoto S.
    Leuk Res; 2006 Aug 01; 30(8):1059-62. PubMed ID: 16330097
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
    Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH.
    Ann Hematol; 2019 Sep 01; 98(9):2163-2177. PubMed ID: 31243569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.